Biotech Rebel Ben Lamm Sparks Buzz With Wild New Claim

In the fast-moving world of biotech innovation, few figures have commanded attention in 2025 the way Ben Lamm has.

As founder and CEO of Colossal Biosciences, he has transformed what sounded like science fiction into a high-stakes, headline-dominating movement.

His company’s mission, once dismissed as sensational, now sits at the center of global discussions about climate solutions, genetics, and the future of life itself.

Ben Lamm’s rise began with a concept that seemed almost too audacious to be real: bringing extinct species back into the modern world.

Colossal Biosciences quickly earned a reputation as the first true “de-extinction” company, aiming to resurrect creatures like the woolly mammoth and the dire wolf, animals that captured imaginations when their early prototypes went viral this year.

However, Colossal’s mission extends far beyond shock value.

Lamm brought a Silicon Valley mindset into synthetic biology: scale fast, pursue the impossible, and prove skeptics wrong.

Backed by his background in AI and software ventures, he reimagined how genetics and computation could work together, and he convinced investors.

With more than $500 million secured, Colossal has evolved from a buzzworthy idea into a formidable scientific enterprise.

The past year marked a turning point for Lamm and his team.

While the public remained fixated on mammoths lumbering across tundra simulations, Colossal quietly built the technologies required to make de-extinction feasible.

Their research into synthetic wombs, next-generation gene-editing tools, and ecological reconstruction created breakthroughs with implications far beyond any one species.

Even Ben Lamm’s highest-profile projects come with deeper purposes. The mammoth initiative is designed to support Arctic grassland restoration as part of a climate-mitigation effort dubbed Pleistocene Park.

In his view, the return of these giant herbivores could reshape landscapes in ways that slow permafrost melt.

To move ambitions this large, Lamm has positioned himself as the conductor of a scientific orchestra, one who attracts elite researchers, investors, and government partners by promoting a grand, almost mythical vision: a future where humanity can undo some of the ecological damage it has caused.

Of course, any mission this radical draws controversy. Critics argue that de-extinction distracts from protecting endangered species already in crisis.

Some claim that resurrecting long-gone creatures is a vanity pursuit rather than a conservation strategy.

Lamm counters that Colossal’s work fuels essential biological breakthroughs with wide-ranging benefits for wildlife and humans alike.

To him, the company’s high-risk scientific approach complements, rather than competes with, traditional conservation.

According to Lamm, Colossal’s next chapter will only accelerate.

In a chat with The Blast, he said, “2026 is shaping up to be a breakthrough year for Colossal. We’re scaling faster than ever — not just in headcount and technology, but in global impact. The partnerships we’re building across government and conservation groups, are opening doors we couldn’t have imagined even a few years ago.”

Lamm added, “This year is all about accelerating our science, expanding internationally, and creating meaningful alliances that move both de-extinction and conservation forward at a pace the world hasn’t seen before.”

His confidence reflects a company shifting from ambitious theory to practical global influence.